Insights

A&M Newsletters
Comprehensive and timely perspectives, on the topics that matter to you, sent straight to your inbox.
Created
Thought Leadership

Will COVID-19 Redefine Market Access in the Life Sciences Sector?

August 4, 2020
In this article A&M are looking at market access itself. They will examine new vulnerabilities in the long and difficult process of getting a drug or treatment to market. They will also investigate ways in which life sciences companies can respond to these challenges and create new, innovative solutions that work for patients and other stakeholders.

Fraud Investigations – Reliance on Legitimate Interests

July 31, 2020
The COVID-19 pandemic has resulted in many organisations seeing a rise in new forms of fraud cases, with investigations, involving the collection and evaluation of large datasets, happening at increasingly short notice. Legitimate interest provides a flexible legal basis under GDPR for fraud investigations but counter-measures are needed to balance the potential impact on individuals.
Thought Leadership

Downsizing your workforce - calculating the cost

July 29, 2020
We recognise these are difficult times, and even with the economic support measures announced on 8th July 2020 by the Chancellor, the reality is that widespread job cuts are now taking place in the UK and with this comes the onerous and complex task of calculating termination payments.
Thought Leadership

Schrems II Aftermath: A Practical Viewpoint

July 27, 2020
Organisations can take a measured approach to evaluate the extent of their exposure to the ramifications of the Court of Justice of the European Union's ruling and to take practical measures to mitigate and manage their cross-border data transfer risks.